RxDoctor Payments Data

Staci Kephart

Physician Assistant · Coalport, PANPI 1619225828

Payments from drug & device makers

$3,286in general payments, 2019–2025

Across 201 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$458
  • Pfizer$402
  • Novo Nordisk$361
  • Lilly USA, LLC$306
  • Amgen$275
  • Amarin Pharma, Inc.$212
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$3,18697%
  • Education$1003%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,286 in reported general payments places this provider in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide85$88,592
JardianceEmpagliflozin53$43,366
Trelegy ElliptaFluticasone/Umeclidin/Vilanter56$38,812
TrulicityDulaglutide31$29,788
EliquisApixaban30$27,310
TradjentaLinagliptin37$26,785
MounjaroTirzepatide20$20,341
XareltoRivaroxaban21$16,121
FarxigaDapagliflozin Propanediol25$14,393
JanuviaSitagliptin Phosphate24$13,369
Breo ElliptaFluticasone/Vilanterol33$12,913
Lantus SolostarInsulin Glargine,hum.Rec.Anlog58$7,809
MyrbetriqMirabegron13$5,884
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,350
Atorvastatin Calcium289$3,133

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$361$88,59285 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$90$57,075101 claims
Lilly USA, LLCTrulicity, Mounjaro$306$50,12951 claims
PfizerEliquis$402$27,31030 claims
Johnson & JohnsonXarelto$141$16,12121 claims
AstraZenecaFarxiga$61$14,39325 claims
MerckJanuvia$88$13,36924 claims
Astellas Pharma US IncMyrbetriq$177$5,88413 claims
AbbVieSynthroid$458$1,50543 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Coalport

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →